Corvus Pharmaceuticals, Inc. (CRVS)

NASDAQ: CRVS · IEX Real-Time Price · USD
-0.230 (-20.91%)
At close: Jun 24, 2022 4:00 PM
+0.150 (17.241%)
After-hours: Jun 24, 2022 7:59 PM EDT

Total Valuation

CRVS has a market cap or net worth of $40.50 million. The enterprise value is -$19.05 million.

Market Cap 40.50M
Enterprise Value -19.05M

Important Dates

The next earnings date is Monday, August 1, 2022, before market open.

Estimated Earnings Date Aug 1, 2022
Ex-Dividend Date n/a

Share Statistics

CRVS has 46.55 million shares outstanding. The number of shares has increased by 34.88% in one year.

Shares Outstanding 46.55M
Shares Change (YoY) +34.88%
Shares Change (QoQ) -0.11%
Owned by Insiders (%) 3.72%
Owned by Institutions (%) 59.29%
Float 28.77M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio 0.45
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 6.95, with a Debt / Equity ratio of 0.04.

Current Ratio 6.95
Quick Ratio 6.83
Debt / Equity 0.04
Debt / EBITDA n/a
Debt / FCF n/a

Financial Efficiency

Return on equity (ROE) is -41.10%, which is considered low. The company has a ROIC of -87.10%.

Return on Equity (ROE) -41.10%
Return on Assets (ROA) -36.40%
Return on Capital (ROIC) -87.10%
Revenue Per Employee n/a
Profits Per Employee -$1.43M
Employee Count 28
Asset Turnover n/a
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -63.96% in the last 52 weeks. The beta is 1.07, so CRVS's price volatility has been similar to the market average.

Beta (1Y) 1.07
52-Week Price Change -63.96%
50-Day Moving Average 1.04
200-Day Moving Average 1.69
Average Volume (30 Days) 268,482

Short Selling Information

The latest short interest is 191,612, so 0.41% of the outstanding shares have been sold short.

Short Interest 191,612
Short % of Shares Out 0.41%
Short % of Float 0.67%
Short Ratio (days to cover) 0.91

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -34.56M
Net Income -39.96M
EBITDA -39.55M
EBIT -39.96M
Earnings Per Share (EPS) -$0.89
Full Income Statement

Balance Sheet

The company has $62.94 million in cash and $3.39 million in debt, giving a net cash position of $59.55 million or $1.28 per share.

Cash & Cash Equivalents 62.94M
Total Debt 3.39M
Net Cash 59.55M
Net Cash Per Share $1.28
Book Value 89.72M
Book Value Per Share 1.93
Working Capital 55.10M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$34.35 million and capital expenditures -$5,000, giving a free cash flow of -$34.36 million.

Operating Cash Flow -34.35M
Capital Expenditures -5,000
Free Cash Flow -34.36M
FCF Per Share n/a
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CRVS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -98.66%
FCF Yield -84.83%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -34.88%
Shareholder Yield -34.88%
Dividend Details

Analyst Forecast

The average price target for CRVS is $6.50, which is 647.13% higher than the current price. The consensus rating is "Buy".

Price Target $6.50
Price Target Difference 647.13%
Analyst Consensus Buy
Analyst Count 10
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a